About Us
The Global Standard for Omics Intelligence
DNAnexus runs the world’s largest omics estates, 140 petabytes and growing 30% a year, for the pharma companies, diagnostic labs, health systems, biobanks, and regulators whose work cannot afford to be wrong. We take on the hard problems, and we take them on as your committed partner.
Our Mission
We build the trusted infrastructure where the world’s omics data and AI come together to advance human health.
Our Vision
A world where omics and AI, working as one, give everyone longer, healthier lives.
Who We Are
We are scientists, engineers, cloud architects and compliance specialists who have spent more than seventeen years learning what it takes to run omics at population scale, regulatory-grade, without breaking. Many of us came from the labs, pharma teams and health systems we now serve. We are committed to solving the hardest problems in human health alongside you.
What We Believe
-
Omics is the molecular language of biology, and the most exciting opportunities in human health depend on our ability to understand biology at the molecular level.
-
Molecular understanding comes first. Earlier diagnosis, sharper treatment and tomorrow’s cures begin there.
-
AI is how the next generation of molecular understanding arrives. What was too vast and too complex to work with is finally within reach.
-
Omics and AI don’t meet on their own. The bridge between them has to be deliberately designed, built, and kept.
-
Progress depends on evolving what exists. We make the systems you already run intelligence-ready rather than asking you to start over.
-
Trust is a discipline, not a feature. Operating at this scale, inside regulation, for more than seventeen years is how we earned it.
Seventeen years in,
three chapters tell our story.
-
2009–2015
Committing to powering the genomics revolution.
DNAnexus was founded in 2009, as sequencing costs collapsed and data volumes exploded, on a bet that genomics belonged in the cloud when much of the field thought that was reckless.
Within a few years the platform was running secondary analysis for the largest diagnostic labs and pharma programs in the world, and in 2015 the FDA chose it to build precisionFDA.
-
2016–2021
Earning trust where the stakes are highest.
GxP, FedRAMP and years of regulated production work followed. In 2021 UK Biobank launched its Research Analysis Platform on DNAnexus, opening the world’s richest biomedical dataset to researchers everywhere.
As the questions crossed modalities, so did our technologies: beyond genomics to every related omics layer, plus the clinical and phenotypic data needed to study whole populations. Over time we were trusted with data reflecting more than 200 million lives.
-
2022 onward
Organizing omics into intelligence.
DNAnexus now secures more than 140 petabytes of omics data and grows by a third every year. This chapter is about transforming your omics data into a standardized, AI-ready and powered asset that your models, agents, and scientists can act on.
Our Values
We own the outcome, not just the deliverable. When your data, your deadline or your audit is on the line, so are we.
We treat the world’s most sensitive data as a responsibility, not a resource, and we earn that trust again with every release.
We put genomics in the cloud before the field even approached the concept. We set the standard and are committed to keeping the bar high.
We are scientists. We ask why, we do the homework, and we come back to you with an answer.
DNAnexus by the Numbers
Security is our standard
Trusted at regulatory grade.
Validated before you log in, audited every year, and proven by the regulator that runs on us.
Meet the team
The people behind the innovation. Scientists, engineers, and a leadership team that has commanded the most exciting advancements in human health.